Prospective Screening for Pancreatic Ductal Adenocarcinoma in High-Risk Individuals

Prospective Screening for Pancreatic Ductal Adenocarcinoma in High-Risk Individuals

Conditions: Pancreatic Cancer; Pancreatic Ductal Adenocarcinoma; PDAC; PDAC – Pancreatic Ductal Adenocarcinoma; Pancreatic Neoplasm
Interventions: Other: Screening Blood Tests; Diagnostic Test: Endoscopic Ultrasound; Combination Product: Magnetic Resonance Imaging; Combination Product: Magnetic Resonance Cholangiopancreatography
Sponsors: Dana-Farber Cancer Institute
Not yet **RECRUITING NOW**

Source: View full study details on ClinicalTrials.gov

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. By listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.

November 9, 2023Comments OffClinicalTrials.gov | Endocrinology Clinical Trials | Endocrinology Studies | US National Library of Medicine
Comments